Literature DB >> 32804409

Clonal evolution and treatment outcomes in hematopoietic neoplasms arising in patients with germline RUNX1 mutations.

Curtis Lachowiez1, Sarah Bannon2, Sanam Loghavi3, Feng Wang4, Rashmi Kanagal-Shamanna3, Rohtesh Mehta5, Naval Daver6, Gautam Borthakur6, Naveen Pemmaraju6, Farhad Ravandi6, Keyur P Patel3, Guillermo Garcia-Manero6, Koichi Takahashi6, Hagop Kantarjian6, Kapil Bhalla6, Courtney D DiNardo6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32804409     DOI： 10.1002/ajh.25965

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  2 in total

Review 1.  The Emerging Role of Hematopathologists and Molecular Pathologists in Detection, Monitoring, and Management of Myeloid Neoplasms with Germline Predisposition.

Authors:  Rashmi Kanagal-Shamanna
Journal:  Curr Hematol Malig Rep       Date:  2021-05-24       Impact factor: 3.952

Review 2.  Beyond Pathogenic RUNX1 Germline Variants: The Spectrum of Somatic Alterations in RUNX1-Familial Platelet Disorder with Predisposition to Hematologic Malignancies.

Authors:  Alisa Förster; Melanie Decker; Brigitte Schlegelberger; Tim Ripperger
Journal:  Cancers (Basel)       Date:  2022-07-14       Impact factor: 6.575
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.